IMM 7.02% 30.5¢ immutep limited

ASX vs NASDAQ, page-103

  1. 9 Posts.
    lightbulb Created with Sketch. 1
    Ahjay - i am surprise that we were the only people that submitted question - as for me i ask the following:

    Do you have any idea on timeframes from preclinical Phase to late stage for IMP 761?
    How will this be funded ?
    Any forwrd intention in diluting stock to raise capital.

    If ELFI 321 AIPAC (Chemo-IO Combo) Metastatic Breast Cancer result are compelling 2H19 what is the time frame on commercialization and generating an income ?
    To me, my focus is still at this stage ELFI 321 AIPAC trail and commercialization- MV stated he will update further news on the next webcast, that in my opinion will drive the share price.
    The actual web cast is very technical so i will view again tomorrow on the company web page
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.020(7.02%)
Mkt cap ! $486.6M
Open High Low Value Volume
29.0¢ 31.0¢ 29.0¢ $1.171M 3.900M

Buyers (Bids)

No. Vol. Price($)
5 101067 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 8068 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.